<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>공통데이터모델(CDM) 실습</title>
    <meta charset="utf-8" />
    <meta name="author" content="김진섭; <span>&lt;i class="fab  fa-github faa-float animated "&gt;&lt;/i&gt;jinseob2kim</span>" />
    <meta name="date" content="2022-06-02" />
    <script src="libs/header-attrs/header-attrs.js"></script>
    <link href="libs/remark-css/default.css" rel="stylesheet" />
    <link href="libs/font-awesome-animation/font-awesome-animation-emi.css" rel="stylesheet" />
    <script src="libs/fontawesome/js/fontawesome-all.min.js"></script>
    <link rel="stylesheet" href="css/footer-header.css" type="text/css" />
  </head>
  <body>
    <textarea id="source">
class: center, middle, inverse, title-slide

.title[
# 공통데이터모델(CDM) 실습
]
.subtitle[
## 고려의대 예방의학교실
]
.author[
### 김진섭; <a href="https://github.com/jinseob2kim"><span>&lt;i class="fab  fa-github faa-float animated "&gt;&lt;/i&gt;jinseob2kim</span></a>
]
.institute[
### 차라투(주)
]
.date[
### 2022-06-02
]

---





layout: true

&lt;div class="my-footer"&gt;&lt;span&gt;&lt;a href="https://www.zarathu.com"&gt;Zarathu Co.,Ltd&lt;/a&gt;   
&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;
&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;&amp;emsp;
&lt;a href="https://github.com/jinseob2kim"&gt;김진섭&lt;/a&gt;&lt;/span&gt;&lt;/div&gt; 


---
# Executive summary

.large[
- Concept set: 약물, 시술, 질병 등 개념 정의

- Cohort definition: Concept set 이용 Target/Comparator/Outcome 코호트 설정

- Analysis: 관찰시간, PS매칭여부, 통계모델 설정

- Meta analysis: Feedernet 다기관분석 합침
]




---
class: center, middle


# 코호트 디자인


---
# The new-user cohort design

![](https://ohdsi.github.io/TheBookOfOhdsi/images/PopulationLevelEstimation/cohortMethod.png)

---
# Main design choices

| Choice            | Description                                              |
|:----------------- |:-------------------------------------------------------- |
| Target cohort     | A cohort representing the target treatment               |
| Comparator cohort | A cohort representing the comparator treatment           |
| Outcome cohort    | A cohort representing the outcome of interest            |
| Time-at-risk      | At what time (often relative to the target and comparator cohort start and end dates) do we consider the risk of the outcome?  |
| Model             | The model used to estimate the effect while adjusting for differences between the target and comparator  |


---
# 실습: 고혈압 약제 비교

Table: Main design choices for our comparative cohort study.

| Choice            | Value                                                    |
|:----------------- |:-------------------------------------------------------- |
| Target cohort     | New users of ACE inhibitors as first-line monotherapy for hypertension. |
| Comparator cohort | New users of thiazides or thiazide-like diuretics as first-line monotherapy for hypertension. |
| Outcome cohort    | Angioedema or acute myocardial infarction. |
| Time-at-risk      | Starting the day after treatment initiation, stopping when exposure stops. |
| Model             | Cox proportional hazards model using variable-ratio matching. |


---
# Concept: ACEI

| Concept Id | Concept Name | Excluded | Descendants | Mapped |
| ---------- |:------------ | -------- | ----------- | ------ |
| 1308216 | Lisinopril | NO | YES | NO |
| 1310756 | moexipril | NO | YES | NO |
| 1331235 | quinapril | NO | YES | NO |
| 1334456 | Ramipril | NO | YES | NO |
| 1335471 | benazepril | NO | YES | NO |
| 1340128 | Captopril | NO | YES | NO |
| 1341927 | Enalapril | NO | YES | NO |
| 1342439 | trandolapril | NO | YES | NO |
| 1363749 | Fosinopril | NO | YES | NO |
| 1373225 | Perindopril | NO | YES | NO |


---
# Concept: Thiazide or thiazide-like diuretic

| Concept Id | Concept Name | Excluded | Descendants | Mapped |
| ---------- |:------------ | -------- | ----------- | ------ |
| 907013 | Metolazone | NO | YES | NO |
| 974166 | Hydrochlorothiazide | NO | YES | NO |
| 978555 | Indapamide | NO | YES | NO |
| 1395058 | Chlorthalidone | NO | YES | NO |


---
# Concept: outcome 

- Angioedema

| Concept Id | Concept Name | Excluded | Descendants | Mapped |
| ---------- |:------------ | -------- | ----------- | ------ |
| 432791 | Angioedema | NO | YES | NO |


- AMI with Inpatient or ER visit

| Concept Id | Concept Name | Excluded | Descendants | Mapped |
| ---------- |:------------ | -------- | ----------- | ------ |
| 314666 | Old myocardial infarction | YES | YES | NO |
| 4329847 | Myocardial infarction | NO | YES | NO |


| Concept Id | Concept Name | Excluded | Descendants | Mapped |
| ---------- |:------------ | -------- | ----------- | ------ |
| 262 | Emergency Room and Inpatient Visit | NO | YES | NO |
| 9201 | Inpatient Visit | NO | YES | NO |
| 9203 | Emergency Room Visit | NO | YES | NO |


---
# Cohort: New ACEI mono

&lt;center&gt;
&lt;img src="https://ohdsi.github.io/TheBookOfOhdsi/images/Cohorts/CohortPractice.png" width=100%&gt;&lt;/a&gt;
&lt;/center&gt;


---

&lt;center&gt;
&lt;img src="acei.png" width=100%&gt;&lt;/a&gt;
&lt;/center&gt;

https://atlas-demo.ohdsi.org/#/cohortdefinition/1775515

---
# New, continuous 365

&lt;center&gt;
&lt;img src="https://ohdsi.github.io/TheBookOfOhdsi/images/Cohorts/EarliestEventExplained.png" width=70%&gt;&lt;/a&gt;
&lt;/center&gt;



---
# Concept for other criteria

Table: Hypertensive disorder

| Concept Id | Concept Name | Excluded | Descendants | Mapped |
| ---------- |:------------ | -------- | ----------- | ------ |
| 316866 | Hypertensive disorder | NO | YES | NO |

Table:  Hypertension drugs

| Concept Id | Concept Name | Excluded | Descendants | Mapped |
| ---------- |:------------ | -------- | ----------- | ------ |
| 904542 | Triamterene | NO | YES | NO |
| 907013 | Metolazone | NO | YES | NO |
| 932745 | Bumetanide | NO | YES | NO |
| 942350 | torsemide | NO | YES | NO |
| 956874 | Furosemide | NO | YES | NO |
| 970250 | Spironolactone | NO | YES | NO |
| 974166 | Hydrochlorothiazide | NO | YES | NO |
| 978555 | Indapamide | NO | YES | NO |
| 991382 | Amiloride | NO | YES | NO |
| 1305447 | Methyldopa | NO | YES | NO |
| 1307046 | Metoprolol | NO | YES | NO |
| 1307863 | Verapamil | NO | YES | NO |
| 1308216 | Lisinopril | NO | YES | NO |
| 1308842 | valsartan | NO | YES | NO |
| 1309068 | Minoxidil | NO | YES | NO |
| 1309799 | eplerenone | NO | YES | NO |
| 1310756 | moexipril | NO | YES | NO |
| 1313200 | Nadolol | NO | YES | NO |
| 1314002 | Atenolol | NO | YES | NO |
| 1314577 | nebivolol | NO | YES | NO |
| 1317640 | telmisartan | NO | YES | NO |
| 1317967 | aliskiren | NO | YES | NO |
| 1318137 | Nicardipine | NO | YES | NO |
| 1318853 | Nifedipine | NO | YES | NO |
| 1319880 | Nisoldipine | NO | YES | NO |
| 1319998 | Acebutolol | NO | YES | NO |
| 1322081 | Betaxolol | NO | YES | NO |
| 1326012 | Isradipine | NO | YES | NO |
| 1327978 | Penbutolol | NO | YES | NO |
| 1328165 | Diltiazem | NO | YES | NO |
| 1331235 | quinapril | NO | YES | NO |
| 1332418 | Amlodipine | NO | YES | NO |
| 1334456 | Ramipril | NO | YES | NO |
| 1335471 | benazepril | NO | YES | NO |
| 1338005 | Bisoprolol | NO | YES | NO |
| 1340128 | Captopril | NO | YES | NO |
| 1341238 | Terazosin | NO | YES | NO |
| 1341927 | Enalapril | NO | YES | NO |
| 1342439 | trandolapril | NO | YES | NO |
| 1344965 | Guanfacine | NO | YES | NO |
| 1345858 | Pindolol | NO | YES | NO |
| 1346686 | eprosartan | NO | YES | NO |
| 1346823 | carvedilol | NO | YES | NO |
| 1347384 | irbesartan | NO | YES | NO |
| 1350489 | Prazosin | NO | YES | NO |
| 1351557 | candesartan | NO | YES | NO |
| 1353766 | Propranolol | NO | YES | NO |
| 1353776 | Felodipine | NO | YES | NO |
| 1363053 | Doxazosin | NO | YES | NO |
| 1363749 | Fosinopril | NO | YES | NO |
| 1367500 | Losartan | NO | YES | NO |
| 1373225 | Perindopril | NO | YES | NO |
| 1373928 | Hydralazine | NO | YES | NO |
| 1386957 | Labetalol | NO | YES | NO |
| 1395058 | Chlorthalidone | NO | YES | NO |
| 1398937 | Clonidine | NO | YES | NO |
| 40226742 | olmesartan | NO | YES | NO |
| 40235485 | azilsartan | NO | YES | NO |


---
# Cohort Exit Criteria

&lt;center&gt;
&lt;img src="https://ohdsi.github.io/TheBookOfOhdsi/images/Cohorts/EarliestEventExplained.png" width=70%&gt;&lt;/a&gt;
&lt;/center&gt;

복용기간 안중요하다면 크게 신경쓸 필요 없음. 


---
# Comparator: New Thiazide

&lt;center&gt;
&lt;img src="aaa.png" width=100%&gt;&lt;/a&gt;
&lt;/center&gt;

https://atlas-demo.ohdsi.org/#/cohortdefinition/1770676


---
# Outcome: Angioedema

&lt;center&gt;
&lt;img src="angioedema.png" width=100%&gt;&lt;/a&gt;
&lt;/center&gt;

https://atlas-demo.ohdsi.org/#/cohortdefinition/1770673


---
# Outcome: AMI

&lt;center&gt;
&lt;img src="ami.png" width=100%&gt;&lt;/a&gt;
&lt;/center&gt;

https://atlas-demo.ohdsi.org/#/cohortdefinition/1770674

---
# Outcome: Negative control

.large[
- 의미없으리라 예상되는 outcome

- 관심없어도 최소 1개는 넣어야 실행됨

- Cohort 필요없고 Concept만 필요.

https://atlas-demo.ohdsi.org/#/conceptset/1866136/expression
]


---
class: center, middle


# 분석 디자인


---
# Study population

&lt;center&gt;
&lt;img src="https://ohdsi.github.io/TheBookOfOhdsi/images/PopulationLevelEstimation/studyPopulation.png" width=70%&gt;&lt;/a&gt;
&lt;/center&gt;


---
# Covariate

.large[
Propensity score 계산때 광범위한 공변량 이용

- 따라서 제외할 공변량 반드시 정의해야함. 특히 Target/Comparator 코호트 내용은 반드시 제외.


광범위 공변량 싫다면 쓸 공변량만 넣을 수도
]

&lt;center&gt;
&lt;img src="https://ohdsi.github.io/TheBookOfOhdsi/images/PopulationLevelEstimation/covariateSettings.png" width=70%&gt;&lt;/a&gt;
&lt;/center&gt;


---
# Concept to exclude

.large[
 코호트 디자인때 설정하면 모든 분석에 적용
]

&lt;center&gt;
&lt;img src="exclude.png" width=100%&gt;&lt;/a&gt;
&lt;/center&gt;


---
# Time at risk

.large[
보통 Cohort start 1일 후부터 살펴봄 
]
&lt;center&gt;
&lt;img src="https://ohdsi.github.io/TheBookOfOhdsi/images/PopulationLevelEstimation/timeAtRisk.png" width=100%&gt;&lt;/a&gt;
&lt;/center&gt;

---
# PS adj
.large[
No matching, matching, stratification(N 손실없음) 중 선택 
]
&lt;center&gt;
&lt;img src="https://ohdsi.github.io/TheBookOfOhdsi/images/PopulationLevelEstimation/psSettings.png" width=70%&gt;&lt;/a&gt;
&lt;/center&gt;


---
# Outcome model

.large[
Cox, logistic 
]
&lt;center&gt;
&lt;img src="https://ohdsi.github.io/TheBookOfOhdsi/images/PopulationLevelEstimation/outcomeModelSettings.png" width=70%&gt;&lt;/a&gt;
&lt;/center&gt;


---
class: center, middle

# Evaluation Settings

---
# Negative Control

.large[
Negative control concept 를 어떻게 코호트로 만들것인가?
]
&lt;center&gt;
&lt;img src="https://ohdsi.github.io/TheBookOfOhdsi/images/PopulationLevelEstimation/ncSettings.png" width=70%&gt;&lt;/a&gt;
&lt;/center&gt;

Postivie Control은 시뮬레이션용. 일단 무시.



---
# Feedernet 

.large[
- My project -&gt; 프로젝트 생성 -&gt; Analysis탭 -&gt; New analysis

- Import from ATLAS 누르고 분석저장한 ATALS로 들어가기 

- 저장한 분석 클릭 

- Execute 누르고 분석할 병원 복수 선택 

]


---
# Meta analysis

.large[
- https://openstat.ai/ 의 meta-analysis 선택: HR, 95%CI 직접 입력 

- 차라투 의뢰..
]

&lt;center&gt;
&lt;img src="meta.png" width=70%&gt;&lt;/a&gt;
&lt;/center&gt;



---
# Executive summary

.large[
- Concept set: 약물, 시술, 질병 등 개념 정의

- Cohort definition: Concept set 이용 Target/Comparator/Outcome 코호트 설정

- Analysis: 관찰시간, PS매칭여부, 통계모델 설정

- Meta analysis: Feedernet 다기관분석 합침
]

---

class: center, middle

# END
    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script src="js/macros.js"></script>
<script>var slideshow = remark.create({
"slideNumberFormat": "<div class=\"progress-bar-container\">\n  <div class=\"progress-bar\" style=\"width: calc(%current% / %total% * 100%);\">\n  </div>\n</div>\n",
"highlightStyle": "github",
"highlightLines": true,
"countIncrementalSlides": false,
"ratio": "4:3"
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
// add `data-at-shortcutkeys` attribute to <body> to resolve conflicts with JAWS
// screen reader (see PR #262)
(function(d) {
  let res = {};
  d.querySelectorAll('.remark-help-content table tr').forEach(tr => {
    const t = tr.querySelector('td:nth-child(2)').innerText;
    tr.querySelectorAll('td:first-child .key').forEach(key => {
      const k = key.innerText;
      if (/^[a-z]$/.test(k)) res[k] = t;  // must be a single letter (key)
    });
  });
  d.body.setAttribute('data-at-shortcutkeys', JSON.stringify(res));
})(document);
(function() {
  "use strict"
  // Replace <script> tags in slides area to make them executable
  var scripts = document.querySelectorAll(
    '.remark-slides-area .remark-slide-container script'
  );
  if (!scripts.length) return;
  for (var i = 0; i < scripts.length; i++) {
    var s = document.createElement('script');
    var code = document.createTextNode(scripts[i].textContent);
    s.appendChild(code);
    var scriptAttrs = scripts[i].attributes;
    for (var j = 0; j < scriptAttrs.length; j++) {
      s.setAttribute(scriptAttrs[j].name, scriptAttrs[j].value);
    }
    scripts[i].parentElement.replaceChild(s, scripts[i]);
  }
})();
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();
// adds .remark-code-has-line-highlighted class to <pre> parent elements
// of code chunks containing highlighted lines with class .remark-code-line-highlighted
(function(d) {
  const hlines = d.querySelectorAll('.remark-code-line-highlighted');
  const preParents = [];
  const findPreParent = function(line, p = 0) {
    if (p > 1) return null; // traverse up no further than grandparent
    const el = line.parentElement;
    return el.tagName === "PRE" ? el : findPreParent(el, ++p);
  };

  for (let line of hlines) {
    let pre = findPreParent(line);
    if (pre && !preParents.includes(pre)) preParents.push(pre);
  }
  preParents.forEach(p => p.classList.add("remark-code-has-line-highlighted"));
})(document);</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
